Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.33 |
| ▸ | NPC1 | O15118 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CTH | P32929 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4740932 | 0.75 | KMT2A (0.46) | RAB9ANPC1TP53MAPTNFKB1 | |
| SCHEMBL4444041 | 0.75 | — | — | |
| SCHEMBL3337245 | 0.69 | — | — | |
| SCHEMBL8862628 | 0.65 | RAB9A (0.43) | RAB9ANPC1TP53MAPTNFKB1 | |
| SCHEMBL3337233 | 0.64 | — | — | |
| SCHEMBL25097159 | 0.62 | KMT2A (0.54) | RAB9ANPC1TP53MAPTNFKB1 | |
| SCHEMBL8862850 | 0.62 | CTH (0.50) | RAB9ANPC1TP53MAPTNFKB1 | |
| SCHEMBL1889092 | 0.59 | BAZ2B (0.50) | RAB9ANPC1TP53MAPTNFKB1 | |
| SCHEMBL4501507 | 0.59 | KMT2A (0.46) | RAB9ANPC1TP53MAPTNFKB1 | |
| SCHEMBL5381046 | 0.58 | KDM4E (0.69) | RAB9ANPC1MAPTSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125762-B1 | ORGANIC MOLYBDENUM COMPOUNDS AND OIL COMPOSITIONS CONTAINING THE SAME | SHELL INT RESEARCH (NL) | 2013-12-11 | — | — | EP | disclosed |
| US-8188017-B2 | Organic molybdenum compounds and oil compositions containing the same | SHELL OIL COMPANY (US) | 2012-05-29 | — | — | US | disclosed |
| US-20100144568-A1 | ORGANIC MOLYBDENUM COMPOUNDS AND OIL COMPOSITIONS CONTAINING THE SAME | SHELL OIL COMPANY | 2010-06-10 | — | — | US | disclosed |
| EP-2125762-A1 | ORGANIC MOLYBDENUM COMPOUNDS AND OIL COMPOSITIONS CONTAINING THE SAME | Shell Internationale Research Maatschappij B.V. (NL) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008092944-A1 | ORGANIC MOLYBDENUM COMPOUNDS AND OIL COMPOSITIONS CONTAINING THE SAME | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2008-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144568-A1 | ORGANIC MOLYBDENUM COMPOUNDS AND OIL COMPOSITIONS CONTAINING THE SAME | F12, C5, C9 | RAB9A 4669/4885NPC1 1493/4885TP53 2688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.